Target intelligence / Profile preview

Exotoxin A of Pseudomonas aeruginosa (ETA (also commonly referred to as PE for "Pseudomonas exotoxin"))

Target
ETA (also commonly referred to as PE for "Pseudomonas exotoxin")
Molecular classification
Enzyme (mono-ADP-ribosyltransferase), Bacterial toxin (exotoxin), Virulence factor
01

Overview

Exotoxin A is the most toxic virulence factor produced by _Pseudomonas aeruginosa_. It is a single-chain polypeptide enzyme secreted extracellularly that catalyzes the transfer of an ADP-ribose moiety from NAD+ onto diphthamide residues on eukaryotic elongation factor 2 (eEF2), thereby irreversibly inhibiting protein synthesis within host cells. Structurally, it consists of three domains responsible respectively for receptor binding, membrane translocation, and catalytic activity. The resulting blockade leads rapidly to cell death and contributes significantly to tissue damage during _P. aeruginosa_ infections such as pneumonia or sepsis. Due to its potent mechanism—and structural similarity with diphtheria toxin—it has also been adapted into engineered immunoconjugates aimed at selectively killing tumor cells.

Other names
Exotoxin AETAPseudomonas exotoxinPENAD(+)--diphthamide ADP-ribosyltransferase (EC 2.4.2.36)
02

Mechanism of action

For drugs using Exotoxin A or its derivatives: — Targeted delivery to specific cells via antibody or ligand binding, followed by internalization and release of the enzymatic domain into the cytoplasm where it catalyzes ADP-ribosylation of eEF2, leading to inhibition of protein synthesis and cell death

03

Biological functions

Inhibition of protein synthesis via ADP-ribosylation of eukaryotic elongation factor 2 (eEF2)Induction of cell death in host cellsPathogenesis/virulence in infection by *Pseudomonas aeruginosa*
04

Disease associations

Infection (*Pseudomonas aeruginosa* pathogenesis; major role in tissue damage during infection)Cancer (used as a cytotoxic payload in immunotoxins for targeted cancer therapy)
05

Safety considerations

High systemic toxicity if not properly targeted; non-specific delivery can cause severe off-target effects due to potent inhibition of protein synthesis in normal tissues.Immunogenicity when used therapeutically as part of immunoconjugates.Resistance mechanisms may arise through mutations affecting toxin uptake pathways.
06

Biomarkers

Presence/titer of anti-exotoxin antibodies may be used experimentally to monitor exposure or immune response.Expression levels or detection of *eta* gene/expression products can serve as markers for pathogenic *P. aeruginosa*.No widely established clinical biomarkers specifically guide patient selection for therapies targeting native exotoxin.

Beyond the preview

Go deeper on Exotoxin A of Pseudomonas aeruginosa (ETA (also commonly referred to as PE for "Pseudomonas exotoxin")).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exotoxin A of Pseudomonas aeruginosa (ETA (also commonly referred to as PE for "Pseudomonas exotoxin")).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call